Results for tag: "Uterine Fibroids Drug"

Uterine Fibroids Drug market is a segment of the Women's Health industry that focuses on the treatment of uterine fibroids. Uterine fibroids are non-cancerous growths that can cause heavy menstrual bleeding, pelvic pain, and other symptoms. Treatment options include medications, minimally invasive procedures, and surgery. Medications used to treat uterine fibroids include gonadotropin-releasing hormone agonists, progestins, androgens, and selective progesterone receptor modulators. Minimally invasive procedures include uterine artery embolization, endometrial ablation, and myolysis. Surgery is the most invasive option and includes hysterectomy and myomectomy. Companies in the Uterine Fibroids Drug market include AbbVie, Bayer, Pfizer, Allergan, and Merck. Show Less Read more